Today: 16 May 2026
AI stock price: C3.ai slips at the close as Fed decision and Big Tech earnings loom
27 January 2026
1 min read

AI stock price: C3.ai slips at the close as Fed decision and Big Tech earnings loom

New York, January 27, 2026, 17:00 EST — After-hours

  • C3.ai ended Tuesday’s session down and showed little movement after hours.
  • Wall Street braces for the Fed’s Jan. 28 decision alongside a surge of megacap tech earnings.
  • AI-linked stocks are reacting to spending and demand signals from Big Tech earnings.

C3.ai (NYSE:AI) shares dropped 2.4% to close Tuesday at $12.62, before edging slightly higher to $12.65 in after-hours trading, which occurs outside the standard 9:30 a.m. to 4 p.m. session.

The decline happened as the S&P 500 notched a record closing high, with investors gearing up for a packed week of earnings reports and a Federal Reserve decision. “The market seems to be hanging in there waiting for a big week of earnings,” said Phil Blancato, chief market strategist at Osaic Wealth, in a Reuters interview. Reuters

The Federal Open Market Committee of the Federal Reserve will convene on Jan. 27-28, with its policy announcement scheduled for Wednesday.

Investors are zeroing in on Big Tech earnings, eager for tangible returns on AI investments. Microsoft and Meta announce results Wednesday, with Alphabet and Amazon due next week, Reuters reported. Microsoft, Meta, and Amazon are all set to boost AI spending by roughly 30%, pushing total outlays beyond $500 billion this year.

C3.ai climbed 1.9% Monday to close at $12.93, though it remains roughly 64% off its 52-week peak of $35.98, MarketWatch reports. Trading volume hit about 4 million shares, falling short of the 50-day average of 5.9 million.

On Dec. 3, C3.ai released its latest quarterly report, showing total revenue of $75.1 million and subscription revenue hitting $70.2 million. The company recorded a GAAP loss of 75 cents per share. It wrapped the quarter with $675 million in cash, cash equivalents, and marketable securities. CEO Stephen Ehikian highlighted the federal market as “a large growth vector” for the firm. C3 AI

High-beta AI stocks have shown they can swing quickly when rates or guidance change, and C3.ai has demonstrated that pattern throughout much of the past year. Chris Zaccarelli, chief investment officer at Northlight Asset Management, told Reuters on Monday that “guidance will be especially important” for the AI trade and described investors as “cautiously optimistic.” Reuters

Wednesday brings the Fed statement, then earnings from Meta, Microsoft, and Tesla, all under close watch for shifts in AI spending or demand signals. C3.ai is set to report earnings March 4, according to TradingView data.

C3.ai faces a straightforward test: can enterprise AI spending translate into rising subscription revenue and larger contracts? The key dates are set — Jan. 28 and March 4 — and the stock is expected to move accordingly.

Stock Market Today

  • Salesforce Stock Climbs 3.7% Amid Analyst Price Target Cuts and Strong Earnings
    May 15, 2026, 7:02 PM EDT. Salesforce Inc. (NYSE:CRM) shares rose 3.7% on Friday, closing at $173.77, supported by higher-than-expected quarterly earnings of $3.81 per share versus estimates of $3.05. The company's revenue also beat estimates, reaching $11.2 billion, up 12.1% year-on-year. However, several Wall Street firms revised their price targets downward, with ranges from $210 to $300, and maintained mixed ratings from "market perform" to "overweight." Salesforce's market capitalization stands at $142.18 billion with a P/E ratio of 22.25. The firm projects FY 2027 earnings per share guidance of 13.110-13.190 and Q1 2027 EPS of 3.110-3.130.

Latest articles

SpaceX Nasdaq Listing Draws Closer as IPO Timeline Accelerates

SpaceX Nasdaq Listing Draws Closer as IPO Timeline Accelerates

16 May 2026
SpaceX plans to list on Nasdaq as early as June 12 under the ticker SPCX, seeking to raise about $75 billion at a $1.75 trillion valuation, sources told Reuters. The company aims to publish its prospectus next week, with investor meetings set for June 4. Bloomberg reported Brookfield has already placed a $2 billion bet ahead of the IPO. SpaceX’s filing includes supervoting shares and strict limits on shareholder proposals.
Broadcom Slips as AI Chip Stocks See Selling

Broadcom Slips as AI Chip Stocks See Selling

16 May 2026
Broadcom shares fell 3.3% to $425.19 on Friday, leading a sector-wide drop in AI-linked chip stocks after a recent rally. No company-specific news triggered the decline. Higher oil prices and Treasury yields fueled inflation concerns, raising expectations that the Federal Reserve could keep interest rates elevated. Nvidia and AMD also posted sharp losses.
Alphabet Drops After Ackman Sells, Tech Stocks Slump

Alphabet Drops After Ackman Sells, Tech Stocks Slump

16 May 2026
Alphabet shares fell 1.1% Friday after Bill Ackman’s Pershing Square disclosed it sold its entire Alphabet stake to fund a new Microsoft position. The Nasdaq dropped 1.54% as rising oil prices and Treasury yields pressured tech stocks. Microsoft rose 3.1% on the news. Alphabet reported Q1 revenue up 22% to $109.9 billion, but raised 2026 capex guidance to as much as $190 billion.
Macy’s up as Berkshire Hathaway buys in; tariffs still on traders’ radar

Macy’s up as Berkshire Hathaway buys in; tariffs still on traders’ radar

16 May 2026
Berkshire Hathaway disclosed a $55 million stake in Macy’s, sending the retailer’s shares up 5.9% in after-hours trading. The position, revealed in a quarterly SEC filing, covers about 3.04 million shares as of March 31. Macy’s board declared a quarterly dividend of 19.15 cents per share, payable July 1. The company forecast lower net sales for fiscal 2026 amid ongoing tariff and consumer spending pressures.
Amazon stock climbs after Whole Foods pivot — what AMZN investors watch before Feb. 5
Previous Story

Amazon stock climbs after Whole Foods pivot — what AMZN investors watch before Feb. 5

CVS stock price dives 14% after CMS Medicare Advantage rate proposal; what investors watch next
Next Story

CVS stock price dives 14% after CMS Medicare Advantage rate proposal; what investors watch next

Go toTop